Skip to content

Efficacy of Sodium Oxybate to promote sleep in the ICU: A randomized controlled trial

Efficacy of Sodium Oxybate to promote sleep in the ICU: A randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON25983
Enrollment
50
Registered
2019-08-28
Start date
2019-06-04
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep disruption in the ICU

Interventions

In this pilot study, a double-blind double-dummy design will be used. One group will receive standard care i.e. temazepam 1 x 20 mg at 22:00 hr and a placebo preparation of SXB at 22.00 hr and 02.00 h

Sponsors

Leiden University Medical Center
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Admission to the ICU/MCU; Expected duration of ICU/MCU admission > 2 nights after detection of sleep difficulties; Awake, conscious (patients can be intubated); RASS (Richmond Agitation-Sedation Scale) score = -2; The patient is experiencing sleep difficulties based on their own or clinical judgment as well as on a low score (<60% average score) on the Richard Campbell Sleep Questionnaire; The ICU physician intends to prescribe general sleep promoting measures as well as a benzodiazepine because of the sleep problems.

Exclusion criteria

Exclusion criteria: Use of sedatives for sleep problems (for example benzodiazepine use) in the last 3 days, except a low dose of Sufentanil (up to 2,5 µg/hr) in intubated patients since this dose is frequently needed to counteract laryngeal tube irritation; Current use of haloperidol, except a maintenance dose in patients recovering from a delirium; RASS score 3; SSADH-deficiency; Severe depression; Planned ICU admission time < 3 nights after detection of sleep difficulties.

Design outcomes

Primary

MeasureTime frame
Sleep efficiency during the designated ICU night period between 22:00 hrs and 06:00 hrs, as determined by polysomnography (PSG) on the second study night.

Secondary

MeasureTime frame
- total sleep time, sleep fragmentation index and total amount of slow wave sleep as determined by polysomnography on the second study night; - total sleep time per night assessed by actigraphy; - incidence of delirium; - outcome parameters of patient- and nurse-derived sleep questionnaire scores (RCSQ).

Contacts

Public ContactMink Schinkelshoek

Leiden University Medical Center

M.S.Schinkelshoek@lumc.nl0031715262118

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)